Sesame Alternatives: Comparing Telehealth GLP-1 Programs

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Sesame or its parent company, and no affiliate links or compensation are involved.

Anyone weighing Sesame is usually also weighing the half-dozen other telehealth programs promising GLP-1 access. This comparison, current as of April 2026, frames where Sesame sits in that landscape, the axes worth comparing across programs, and one dimension almost none of them cover.

The telehealth GLP-1 category at a glance

The market that Sesame competes in is crowded with subscription clinics, marketplace platforms, and pharmacy-linked services, all routing patients toward semaglutide or tirzepatide. On the surface the offers look interchangeable; underneath, they diverge on provider model, pharmacy pathway, pricing structure, and how much clinical follow-up is actually included. Naming a single option as the right one for everyone would be misleading — fit depends on your situation. The result is a market where marketing language converges even as the operational details underneath stay meaningfully different from one program to the next.

How Sesame's marketplace model works

Sesame (Sesame Care) operates as marketplace telehealth rather than a single-brand clinic. Programs in this model typically include a virtual clinical evaluation by a licensed provider, a written prescription routed to either a retail pharmacy for FDA-approved brand products or a 503A compounding pharmacy for compounded semaglutide or tirzepatide, and ongoing follow-up. Check Sesame's official website for its current structure and pricing.

What to weigh when comparing programs

A fair comparison across alternatives comes down to a few repeatable questions: Is the prescriber a physician, NP, or PA? Does the medication come from a retail pharmacy or a licensed compounding pharmacy? Is pricing a flat monthly figure or an unbundled stack of visit and medication fees? And how much titration support and messaging access is built in? Two programs at the same headline price can differ sharply once these are answered. Writing those answers down side by side turns an overwhelming set of options into a short, decidable checklist.

The evidence common to every legitimate option

Whatever platform dispenses it, the pharmacology is identical: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide). The evidence rests on STEP (semaglutide for weight management, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Trial populations and endpoints vary, and outcomes vary individually. That shared foundation means the choice between programs rarely hinges on the compound itself and far more on service, sourcing, and support.

The comparison axis most programs skip: genetics

Here is the dimension the alternatives rarely compete on. None of them read the upstream genetic architecture behind a GLP-1 response. Variants in FTO, GLP1R, MC4R, and TCF7L2 map the baseline metabolic terrain any compound has to work on. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights. It does not predict response to any program or compound; it describes the biology a prescription is written into. Treating genetics as a comparison axis, rather than an afterthought, reframes the decision from picking a vendor to understanding your own metabolism.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral — paired with that genetic context. Not affiliated: PlexusDx has no commercial relationship with Sesame or the companies named here.

Related reading on PlexusDx: GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1, GLP 1 What Is.

Frequently Asked Questions

What are the main alternatives to Sesame?

The category includes subscription weight clinics, marketplace platforms, and pharmacy-linked telehealth services, all routing toward semaglutide or tirzepatide. They differ on provider type, pharmacy pathway, and pricing structure rather than the underlying compound. Compare those variables directly on each provider's own site before deciding which fits your situation.

How is Sesame different from a single-brand clinic?

Sesame runs as a marketplace connecting patients to independent listed providers, whereas single-brand clinics employ their own clinical team. That can affect provider consistency, pricing transparency, and how follow-up is handled. Neither model is inherently better; the right choice depends on how much continuity and bundled support you want.

Does any alternative include genetic testing?

Most telehealth GLP-1 programs, Sesame included, do not analyze your genetics. PlexusDx pairs its protocols with the Precision Peptide Genetic Test, which reads pathway variants in FTO, MC4R, and TCF7L2. That upstream context is the axis the majority of alternatives simply do not offer alongside the medication.

How should I choose between them?

Line up provider type, pharmacy pathway, total monthly cost, and included follow-up across each option, then verify the details on the provider's own website. Consider whether upstream genetic context matters to you. Any final decision about a GLP-1 protocol belongs in a conversation with a qualified healthcare provider.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.